Xiaoping Wan
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments
Papers in
-
- Endometrial and Cervical Cancer Treatments 15
- Oncology 24
- Cancer Cells and Metastasis 8
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Yinyan He (8 shared papers)Qi Che (13 shared papers)Shuangdi Li (11 shared papers)Fangyuan Wang (11 shared papers)Yun Jun Liao (10 shared papers)Bilan Li (4 shared papers)Kai Wang (9 shared papers)Wei Bao (6 shared papers)
- Journals
- PLoS ONE (5 papers)Oncology Reports (4 papers)BMC Cancer (3 papers)Biochemical and Biophysical Research Communications (3 papers)Cancer Letters (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xiaoping Wan
95 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 92
- Cancer Research 595
- Obstetrics and Gynecology 276
- Oncology 602
- Reproductive Medicine 204
- Molecular Biology 1.2k
Countries citing papers authored by Xiaoping Wan
This map shows the geographic impact of Xiaoping Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Wan more than expected).
Fields of papers citing papers by Xiaoping Wan
This network shows the impact of papers produced by Xiaoping Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Wan. The network helps show where Xiaoping Wan may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Wan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 96 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 264 | |
| 2 | 2018 | 230 | |
| 3 | 2008 | 105 | |
| 4 | 2016 | 97 | |
| 5 | 2018 | 89 | |
| 6 | 2011 | 86 | |
| 7 | 2020 | 85 | |
| 8 | 2011 | 82 | |
| 9 | 2020 | 76 | |
| 10 | 2020 | 75 | |
| 11 | 2013 | 72 | |
| 12 | 2013 | 66 | |
| 13 | 2014 | 64 | |
| 14 | 2016 | 64 | |
| 15 | 2012 | 63 | |
| 16 | 2013 | 62 | |
| 17 | 2018 | 59 | |
| 18 | 2023 | 53 | |
| 19 | 2018 | 52 | |
| 20 | 2020 | 52 |
About Xiaoping Wan
Xiaoping Wan is a scholar working on Obstetrics and Gynecology, Oncology, Molecular Biology, Cancer Research and Reproductive Medicine, having authored 96 papers that have together received 3.3k indexed citations. Recurring topics across this work include Endometrial and Cervical Cancer Treatments (15 papers), Epigenetics and DNA Methylation (9 papers), Estrogen and related hormone effects (9 papers), Cancer Cells and Metastasis (8 papers), Ovarian cancer diagnosis and treatment (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Pluripotent Stem Cells Research (6 papers) and DNA Repair Mechanisms (6 papers). The work is most often cited by research in Cancer Research (595 citations), Obstetrics and Gynecology (276 citations), Oncology (602 citations), Reproductive Medicine (204 citations) and Molecular Biology (1.2k citations). Xiaoping Wan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Yinyan He, Qi Che, Shuangdi Li, Fangyuan Wang, Yun Jun Liao, Bilan Li, Kai Wang, Wei Bao, Yixia Yang and Mengfei Wang. Their work appears in journals such as PLoS ONE, Oncology Reports, BMC Cancer, Biochemical and Biophysical Research Communications and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.